VALIDATION OF THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM AND TRANSPLANTATION RISK INDEX ON POSTTRANSPLANTATION OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
Yahng, S. [1 ]
Jeon, Y. W. [2 ]
Yoon, J. H. [2 ]
Shin, S. H. [3 ]
Lee, S. E. [2 ]
Choi, Y. S. [4 ]
Kim, D. Y. [4 ]
Lee, J. H. [4 ]
Eom, K. S. [2 ]
Lee, S. [2 ]
Min, C. K. [2 ]
Kim, H. J. [2 ]
Lee, J. W. [2 ]
Lee, K. H. [4 ]
Min, W. S. [2 ]
Lee, J. H. [4 ]
Kim, Y. J. [2 ]
机构：
[1] Catholic Univ Korea, Incheon St Marys Hosp, Hematol, Inchon, South Korea
[2] Catholic Univ Korea, Hematol, Catholic Blood & Marrow Transplantat Ctr, Seoul St Marys Hosp, Seoul, South Korea
[3] Catholic Univ Korea, Yeoido St Marys Hosp, Hematol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Hematol, Seoul, South Korea
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30260-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
259
引用
收藏
页码：S129 / S130
页数：3
相关论文
共 50 条
  • [31] A five parameter based flow cytometric scoring system refines the revised International Prognostic Scoring System for myelodysplastic syndromes
    Alhan, C.
    Westers, T. M.
    Cremers, E. M. P.
    Cali, C.
    Ossenkoppele, G. J.
    Van de Loosdrecht, A. A.
    LEUKEMIA RESEARCH, 2013, 37 : S64 - S64
  • [32] Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes
    Zhao, Youshan
    Guo, Juan
    Zhao, Sida
    Wang, Roujia
    Wu, Dong
    Chang, Chunkang
    LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 100 - 108
  • [33] Improving Risk Stratification of Patients with Myelodysplastic Syndromes By the Integration of Red Blood Cell Transfusion Dependency into the Revised International Prognostic Scoring System
    Arnan, Montserrat
    Pomares, Helena
    Sanchez-Ortega, Isabel
    Alonso, Ester
    Condom, Maria
    Encuentra, Maite
    Grau, Javier
    Sureda, Anna
    BLOOD, 2016, 128 (22)
  • [34] Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
    Sauta, Elisabetta
    Robin, Marie
    Bersanelli, Matteo
    Travaglino, Erica
    Meggendorfer, Manja
    Zhao, Lin-Pierre
    Caballero Berrocal, Juan Carlos
    Sala, Claudia
    Maggioni, Giulia
    Bernardi, Massimo
    Di Grazia, Carmen
    Vago, Luca
    Rivoli, Giulia
    Borin, Lorenza
    D'Amico, Saverio
    Tentori, Cristina Astrid
    Ubezio, Marta
    Campagna, Alessia
    Russo, Antonio
    Mannina, Daniele
    Lanino, Luca
    Chiusolo, Patrizia
    Giaccone, Luisa
    Voso, Maria Teresa
    Riva, Marta
    Oliva, Esther Natalie
    Zampini, Matteo
    Riva, Elena
    Nibourel, Olivier
    Bicchieri, Marilena
    Bolli, Niccolo'
    Rambaldi, Alessandro
    Passamonti, Francesco
    Savevski, Victor
    Santoro, Armando
    Germing, Ulrich
    Kordasti, Shahram
    Santini, Valeria
    Diez-Campelo, Maria
    Sanz, Guillermo
    Sole, Francesc
    Kern, Wolfgang
    Platzbecker, Uwe
    Ades, Lionel
    Fenaux, Pierre
    Haferlach, Torsten
    Castellani, Gastone
    Della Porta, Matteo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2827 - +
  • [35] THE ASSESSMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROME ACCORDING TO REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM
    Bolaman, A. Z.
    Yavasoglu, I.
    Kadikoylu, V. G.
    Pektas, G.
    HAEMATOLOGICA, 2014, 99 : 625 - 625
  • [36] Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndrome
    Kewan, Tariq
    Bahaj, Waled
    Aly, Mai
    Durmaz, Arda
    Ogbue, Olisaemeka
    Carraway, Hetty E.
    Singh, Abhay Singh
    Balasubramanian, Suresh Kumar
    Sekeres, Mikkael A.
    Visconte, Valeria
    Gurnari, Carmelo
    Maciejewski, Jaroslaw P.
    BLOOD, 2022, 140 : 6942 - 6944
  • [37] Validating the Lower-Risk MD Anderson Prognostic Scoring System (LR-PSS) and the Revised International Prognostic Scoring System (IPSS-R) for Patients with Myelodysplastic Syndromes
    Sekeres, Mikkael A.
    Elson, Paul
    Tiu, Ramon V.
    Saunthararajah, Yogen
    Advani, Anjali S.
    Paulic, Katarina
    Chan, Josephine
    Pierce, Sherry
    Jabbour, Elias
    Kantarjian, Hagop M.
    Maciejewski, Jaroslaw P.
    Garcia-Manero, Guillermo
    BLOOD, 2011, 118 (21) : 749 - 750
  • [38] Validation of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model for Myelodysplastic Syndromes
    Aguirre, Luis E.
    Al Ali, Najla
    Ball, Somedeb
    Singh, Avani M.
    Jain, Akriti G.
    Chan, Onyee
    Schwabkey, Zaker, I
    Tinsley-Vance, Sara M.
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    BLOOD, 2022, 140 : 1125 - 1127
  • [39] International prognostic scoring system and other prognostic systems for myelodysplastic syndromes
    Balduini, CL
    Guarnone, R
    Pecci, A
    Centenara, E
    Ascari, E
    BLOOD, 1997, 90 (10) : 4232 - 4233
  • [40] Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study
    Neukirchen, Judith
    Lauseker, Michael
    Blum, Sabine
    Giagounidis, Aristoteles
    Luebbert, Michael
    Martino, Samuela
    Siragusa, Sergio
    Schlenk, Richard F.
    Platzbecker, Uwe
    Hofmann, Wolf-Karsten
    Goetze, Katharina
    Palumbo, Giuseppe A.
    Magrin, Silvana
    Kuendgen, Andrea
    Aul, Carlo
    Hildebrandt, Barbara
    Hasford, Joerg
    Kobbe, Guido
    Haas, Rainer
    Germing, Ulrich
    LEUKEMIA RESEARCH, 2014, 38 (01) : 57 - 64
12345